Our @CenterTBI team in Rotterdam, the Netherlands, @ErasmusMCPH is involved in research on prediction of outcome, multidimensional classification of #TBI, identifying effective clinical care, and between-center and between-country differences in outcome & care following #TBI.
@Dr_Cit @CenterTBI @TheLancetNeuro@Menon_Cambridge@hesterlingsma Great discussions on the way forward at @CenterTBI meeting on “Tackling TBI in the 21st century”; reflections on what has been achieved in this 30M EU funded project, including many publications and impressive PhD theses https://t.co/fntRqwhM2B and top 3 research questions
@Dr_Cit @CenterTBI @TheLancetNeuro@Menon_Cambridge@hesterlingsma Highlights of Comparative effectiveness Research were presented by @HesterLingsma, with a discussion on where to do RCTs to provide firmer evidence.
And a discussion on Federated Learning as the new way to do data analysis on combined data.
Our @CenterTBI paper on the incremental value of acute serum biomarkers for the prediction of functional outcome after traumatic brain injury is out now @TheLancetNeuro https://t.co/wJoZin2Qsi
Rates of traumatic brain injury (TBI) are increasing in older adults.
Our new paper describes health care utilization, and 6-month outcomes and their predictors in TBI patients aged 65+ from @CenterTBI https://t.co/0b5dofM4QP
Exciting that our paper was one of the most read in @J_Neurotrauma in 2021: Differences between men and women in treatment and outcome after traumatic brain injury!
Why do men and women differ in outcomes following mild traumatic brain injury?
Can the sex/gender differences in 6-month outcomes after mTBI in @CenterTBI be explained by psychiatric history, care pathways and/or sociodemographic variables?
@J_Neurotrauma https://t.co/O82yYRi4mS
@CenterTBI paper showing significant inter-centre differences in WLST withdrawal in TBI - not underpinned by evidence or explained by rational differences in clinical practice. This paper provides a foundation for future research. @CuringComa
Withdrawal of life support in TBI:
🧠variable occurrence between regions 0-96%, no influence on timing
🧠WLSM early (<72 h) in ½ of pts (mostly severe TBI involving brainstem): strongest associated variables 1 or 2 unreactive pupils & ISS if >41
@CenterTBI https://t.co/FjbUFizMWB
Happy with our paper in @TheLancetNeuro on comparative effectiveness of fluid management strategies in TBI patients in the ICU. Successful example of treatment effect estimation in observational data. @CenterTBI @Menon_Cambridge@Dr_Cit@ESteyerberg
https://t.co/TMzhkd1SZz
🎓Tomorrow, Thursday March 18, 15.30 CET, Jilske Huijben will defend her #PhD thesis "Assessment and Improvement of Intensive Care for patients with Traumatic Brain Injury" 🏥🛌 #TBI#ICU @CenterTBI More information 👉 https://t.co/vA50YnWjoq
Did the IMPACT & CRASH models, developed a decade ago, stand the test of time? Ext. validation of these models in contemporary #TBI patients in @CenterTBI showed adequate discrimination but variable calibration. https://t.co/z1HmeLtQpj
Accurate prediction of outcome following #TBI is essential for research and clinical care. Learn more about the performance of two established prognostic models in contemporary patients after TBI in the @CenterTBI study. By @IRetelHelmrich
Two of our researchers @BGravesteijn and @IRetelHelmrich will present results from @CenterTBI studies on acute care and outcome prediction in #TBI at the #RCEM trainee Research Engagement Day next week (14 jan). @RCEMevents
Very excited for the RCEM Trainee Research Engagement Day 14th Jan 2021. Updates from TERN, @ITERN_@ResearchPHOTON - and that's just our 30m. I'll try to tag everyone but it'll take a while - if you're even slightly interested in EM research head to: https://t.co/jUm56QgbZx
CENTER-TBI (@CenterTBI) brings the newest technologies and many of the world’s leading TBI experts together in a much-needed effort to tackle the silent epidemic of TBI.
Find out more today. 👇
#TBI#MedicalTechnology#Innovation
https://t.co/wt8nFAmLO1